Release Date: 31/12/13 09:37 Summary: Resignation of Alternate Director Price Sensitive: No Download Document 261.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%